Drug intelligence / Profile preview

dextran 70 + glucose

Development stage
Unknown
Lead developer
Pharmacosmos
Modality
Small Molecules
Administration
Intravenous
01

Overview

Dextran 70 + glucose (commonly referred to as Dextran 70 in 5% Dextrose) is a sterile, non-pyrogenic intravenous solution used as a plasma volume expander. It consists of dextran 70, a high-molecular-weight branched polysaccharide (average molecular weight of 70,000 Daltons) produced by the fermentation of sucrose by *Leuconostoc mesenteroides*, and glucose (dextrose). The formulation acts as a colloid, increasing the oncotic pressure of the blood and pulling water from the extravascular space into the blood vessels. This expansion of plasma volume improves hemodynamics, cardiac output, and tissue perfusion in patients suffering from hypovolemic shock due to hemorrhage, surgery, or trauma. While it is included on the WHO List of Essential Medicines, its clinical use has declined in favor of other crystalloids and colloids due to risks of anaphylaxis, renal dysfunction, and interference with blood cross-matching and coagulation.

Other names
Dextran 70 + dextroseDextran 70 6% in 5% DextroseDextran 70 in 5% dextrose

Beyond the preview

Go deeper on dextran 70 + glucose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextran 70 + glucose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call